Therapy, Solid Tumors II

Differentiation therapy with new biological agents

Scott M. Lippman, M.D. and Waun Ki Hong, M.D.,UT M. D. Anderson Cancer Center, Houston, TX

Tumor cells transfected with allogeneic MHC class II genes induce protective antitumor immune responses

GN Callahan, DR Leach

Angiogenesis and breast cancer

Daniel F. Haynes M,D, Medical Director,

Preliminary report on the use of antisense dna in the treatment of chronic myelogenous leukemia

AM Gewirtz